Mark Behlke
Chief Scientific Officer
InterDigital, Inc.
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Mark Behlke is the Chief Scientific Officer at Integrated DNA Technologies Inc in the United States. His research focuses on gene editing and therapy, with recent publications involving gene replacement techniques for β-thalassemia, CRISPR-Cas9 genome editing applications in cancer therapy, and the systematic profiling of CRISPR enzyme efficiencies and off-target effects.
Articles (3)
Year:
2021
Year:
2020
Year:
2020
Collaborators (2)
Kyle Cromer
Assistant Professor
University of California, San Francisco
UNITED STATES
Miles Pufall
Associate Professor
The University of Iowa University College
UNITED STATES
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.